Susquehanna International Group
FPRX

Susquehanna International Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Susquehanna International Group’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-29,986
Closed -$1.13M – 13720
2021
Q1 		$1.13M Buy
29,986
+10,813
+56% +$270K ﹤0.01% 7408
2020
Q4 		$326K Buy
+19,173
New +$240K ﹤0.01% 9114
2020
Q3 		– Sell
-90,596
Closed -$460K – 11438
2020
Q2 		$553K Buy
90,596
+53,882
+147% +$222K ﹤0.01% 7159
2020
Q1 		$83K Sell
36,714
-31,574
-46% -$134K ﹤0.01% 9437
2019
Q4 		$313K Buy
68,288
+1,198
+2% +$4.75K ﹤0.01% 7937
2019
Q3 		$260K Sell
67,090
-7,635
-10% -$41.9K ﹤0.01% 8614
2019
Q2 		$451K Buy
+74,725
New +$714K ﹤0.01% 7476
2015
Q4 		– Sell
-44,786
Closed -$1.5M – 10209
2015
Q3 		$689K Buy
44,786
+27,609
+161% +$593K ﹤0.01% 6489
2015
Q2 		$427K Sell
17,177
-14,300
-45% -$319K ﹤0.01% 7923
2015
Q1 		$719K Buy
+31,477
New +$794K ﹤0.01% 6405

Susquehanna International Group's FPRX Position: Q2 2021 in Review

Susquehanna International Group sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 29,986 shares — an estimated $1.13M sold.

Susquehanna International Group first reported a position in FPRX in Q1 2015 and held it in 10 quarters. The position peaked at $1.13M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Susquehanna International Group reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Susquehanna International Group sold 29,986 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $1.13M.
  • Susquehanna International Group first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 10 quarters.
  • Susquehanna International Group's Five Prime Therapeutics, Inc. position peaked at $1.13M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.